Syndax Pharmaceuticals to participate in four investor conferences

SNDX•2026-10-30

Syndax Pharmaceuticals CEO Michael A. Metzger and management will participate in four investor conferences in November 2026, with fireside chats scheduled from Nov. 10 to Nov. 19.

1. Conference schedule

Syndax Pharmaceuticals CEO Michael A. Metzger and management will participate in four investor conferences in November 2026. Fireside chats are scheduled for Nov. 10 in Boston, Nov. 12 in New York, and Nov. 17 and Nov. 19 in London.

Syndax Pharmaceuticals to participate in four investor conferences

1. Conference schedule

Related News

OmniAb Q3 revenue beats on antibody, ion channel program growth

Thermo Fisher Scientific target price raised to $780 from $560

Allarity Therapeutics secures first lab services contract with European biotech company

L3Harris Technologies target price raised to $335 from $318 by Bernstein

Antero Resources target price raised to $52 from $46